Aug 2026· Discover Oncology· Vol 17· 0 citations· 27 references
TL;DR
It is demonstrated that POLQ correlates with immune infiltration in HCC and may serve as a novel prognostic biomarker.
Abstract
Hepatocellular carcinoma (HCC) is a common malignancy with a poor prognosis. DNA polymerase theta (POLQ) plays multiple roles in HCC, primarily in DNA damage repair, tumor progression, and resistance to chemoradiotherapy. However, the upstream and downstream signaling pathways regulated by POLQ, along with its association with immune cell infiltration, remain unclear. We conducted comprehensive bioinformatics analyses to evaluate POLQ expression in HCC versus normal tissues using data from TCGA and Genotype-Tissue Expression databases. Functional enrichment analyses, including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), gene set enrichment analysis (GSEA), and single-sample GSEA (ssGSEA), explored POLQ’s biological functions and immune-related pathways. Its prognostic significance was assessed via Kaplan–Meier (KM) survival analysis and univariate and multivariate Cox regression models. Immunohistochemistry (IHC) validated POLQ protein expression in HCC and adjacent normal tissues. POLQ expression was significantly upregulated in HCC tissues compared to normal controls. GO, KEGG, and GSEA analyses revealed POLQ’s involvement in key processes such as nuclear division, antigen binding, immunoglobulin receptor binding, and cell cycle regulation. ssGSEA showed positive correlations between POLQ expression and infiltration of T helper (Th)2 and Th cells, but negative associations with activated Th17, dendritic, cytotoxic, and CD8 + T cells. KM curve analyses indicated that high POLQ expression predicted shorter overall survival, disease-specific survival, and progression-free interval in patients with HCC. Univariate and multivariate Cox regression confirmed POLQ as an independent prognostic risk factor. IHC results showed significantly higher POLQ protein levels in HCC tissues than in adjacent normal liver tissue. These findings demonstrate that POLQ correlates with immune infiltration in HCC and may serve as a novel prognostic biomarker.
Background: Telomerase is a ribonucleic multimeric reverse transcriptase complex protecting the chromosomal ends from erosion and thereby from cellular senescence. The prognostic value of the components of this complex and their interrelationships with the immune system are not well understood. Objectives: We aimed to...
Axel Guthart, Edna Ooko, Thomas Efferth et al.· DNA· 0 citations
The findings suggest that POLQ is a potential prognostic biomarker and therapeutic target, Though further validation in prospective, multicenter cohorts is warranted, andBioinformatic inference suggests a potential association with an immunosuppressive microenvironment, but this finding remains correlative and requires...
Li Li, Jian-Hua Wang, Fei-Long Zhou et al.· Oncology Research· 0 citations
Hepatocellular carcinoma (HCC) is one of the malignant tumors with high incidence and mortality rates worldwide. Given the poor prognosis of patients with HCC, it is crucial to explore the molecular mechanisms underlying HCC development and to evaluate prognostic markers. Differential expression analysis followed by un...
Yu-Xian Liu, Xing-Jie Chen, Jun-Yuan Zhang et al.· International Journal of Mol...· 0 citations
Hepatocellular carcinoma (HCC) is a major cause of cancer-related mortality worldwide and has a poor prognosis. Long non-coding RNAs (lncRNAs) are important regulators of cancer biology; however, the expression pattern, clinical significance, and biological relevance of LINC02163 in HCC remain insufficiently char...
A seven-gene immune-related prognostic signature that, combined with clinicopathological parameters, provides a robust tool for individualized survival prediction and may guide precision management in CRC patients is developed and validated.
TGF-β receptor 1 (TGFBR1) is a key component of TGF-β signaling and has been implicated in tumor progression. However, its expression patterns, prognostic relevance and associated molecular contexts vary among malignancies and remain incompletely characterized within a consistent pan-cancer framework. In the present st...
Xia Zhao, Lu-Fan Shen, Zhi-Yuan Gong et al.· Oncology Letters· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.